Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictions

被引:19
作者
Eden, Michael [1 ]
Harrison, Samantha [2 ]
Griffin, Michelle [3 ]
Lambe, Mats [4 ]
Pettersson, David [5 ]
Gavin, Anna [6 ]
Brewster, David H. [7 ]
Lin, Yulan [8 ]
Johannesen, Tom B. [9 ]
Milne, Roger L. [10 ]
Farrugia, Helen [11 ]
Nishri, Diane [12 ]
King, Mary-Jane [13 ]
Huws, Dyfed W. [14 ]
Warlow, Janet [14 ]
Turner, Donna [15 ]
Earle, Craig C. [16 ]
Peake, Michael [1 ,17 ]
Rashbass, Jem [3 ]
机构
[1] NCRAS, London, England
[2] Canc Res UK, Policy & Informat, Oakham, England
[3] Publ Hlth England, Natl Dis Registrat, London, England
[4] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[5] Natl Board Hlth & Welf, Stockholm, Sweden
[6] Queens Univ Belfast, N Ireland Canc Registry, Belfast, Antrim, North Ireland
[7] NHS Natl Serv Scotland, Scottish Canc Registry, Edinburgh, Midlothian, Scotland
[8] Norwegian Univ Sci & Technol NTNU, European Palliat Care Res Ctr PRC, Dept Clin & Mol Med, Trondheim, Norway
[9] Canc Registry Norway, Oslo, Norway
[10] Canc Council Victoria, Canc Epidemiol & Intelligence Div, Melbourne, Vic, Australia
[11] Canc Council Victoria, Victorian Canc Registry, Melbourne, Vic, Australia
[12] Canc Care Ontario, Prevent & Canc Control, Toronto, ON, Canada
[13] Canc Care Ontario, Ontario Canc Registry, Toronto, ON, Canada
[14] Publ Hlth Wales, Welsh Canc Intelligence & Surveillance Unit, Cardiff, S Glam, Wales
[15] CancerCare Manitoba, Epidemiol & Canc Registry, Winnipeg, MB, Canada
[16] Ontario Inst Canc Res, Inst Clin Evaluat Sci, Toronto, ON, Canada
[17] Univ Leicester, Resp Med, Leicester, Leics, England
关键词
Cancer survival; Cancer registration; Date of diagnosis; Death certificate; Multiple primaries; International comparisons; DEATH CERTIFICATE; COMPLETENESS; DIAGNOSIS; PATIENT; 1ST;
D O I
10.1016/j.canep.2018.10.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: International cancer survival comparisons use cancer registration data to report cancer survival, which informs the development of cancer policy and practice. Studies like the International Cancer Benchmarking Partnership (ICBP) have a duty to understand how registration differences impact on survival prior to drawing conclusions. Methods: Key informants reported differences in registration practice for capturing incidence date, death certificate case handling and registration of multiple primary tumours. Sensitivity analyses estimated their impact on one-year survival using baseline and supplementary cancer registration data from England and Sweden. Results: Variations in registration practice accounted for up to a 7.3 percentage point difference between unadjusted (estimates from previous ICBP survival data) and adjusted (estimates recalculated accounting for registration differences) one-year survival, depending on tumour site and jurisdiction. One-year survival estimates for four jurisdictions were affected by adjustment: New South Wales, Norway, Ontario, Sweden. Sweden and Ontario's survival reduced after adjustment, yet they remained the jurisdictions with the highest survival for breast and ovarian cancer respectively. Sweden had the highest unadjusted lung cancer survival of 43.6% which was adjusted to 39.0% leaving Victoria and Manitoba with the highest estimate at 42.7%. For colorectal cancer, Victoria's highest survival of 85.1% remained unchanged after adjustment. Conclusion: Population-based cancer survival comparisons can be subject to registration biases that may impact the reported 'survival gap' between populations. Efforts should be made to apply consistent registration practices internationally. In the meantime, survival comparison studies should provide acknowledgement of or adjustment for the registration biases that may affect their conclusions.
引用
收藏
页码:184 / 192
页数:9
相关论文
共 27 条
  • [1] Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
    Allemani, Claudia
    Weir, Hannah K.
    Carreira, Helena
    Harewood, Rhea
    Spika, Devon
    Wang, Xiao-Si
    Bannon, Finian
    Ahn, Jane V.
    Johnson, Christopher J.
    Bonaventure, Audrey
    Marcos-Gragera, Rafael
    Stiller, Charles
    Azevedo e Silva, Gulnar
    Chen, Wan-Qing
    Ogunbiyi, Olufemi J.
    Rachet, Bernard
    Soeberg, Matthew J.
    You, Hui
    Matsuda, Tomohiro
    Bielska-Lasota, Magdalena
    Storm, Hans
    Tucker, Thomas C.
    Coleman, Michel P.
    [J]. LANCET, 2015, 385 (9972) : 977 - 1010
  • [2] [Anonymous], CANC INC SWED 2010
  • [3] Pathways to the diagnosis of lung cancer in the UK: a cohort study
    Barrett, Jacqueline
    Hamilton, William
    [J]. BMC FAMILY PRACTICE, 2008, 9 (1)
  • [4] Bethesda M. D., 2007, MULTIPLE PRIMARY HIS, V2007
  • [5] Evaluation of data quality in the cancer registry: Principles and methods. Part I: Comparability, validity and timeliness
    Bray, Freddie
    Parkin, D. Max
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (05) : 747 - 755
  • [6] Population-based monitoring of cancer patient survival in situations with imperfect completeness of cancer registration
    Brenner, H
    Hakulinen, T
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (03) : 576 - 579
  • [7] Incidence of second primary cancers in three Italian population-based cancer registries
    Buiatti, E
    Crocetti, E
    Acciai, S
    Gafa, L
    Falcini, F
    Milandri, C
    LaRosa, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (11) : 1829 - 1834
  • [8] Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data
    Coleman, M. P.
    Forman, D.
    Bryant, H.
    Butler, J.
    Rachet, B.
    Maringe, C.
    Nur, U.
    Tracey, E.
    Coory, M.
    Hatcher, J.
    McGahan, C. E.
    Turner, D.
    Marrett, L.
    Gjerstorff, M. L.
    Johannesen, T. B.
    Adolfsson, J.
    Lambe, M.
    Lawrence, G.
    Meechan, D.
    Morris, E. J.
    Middleton, R.
    Steward, J.
    Richards, M. A.
    [J]. LANCET, 2011, 377 (9760) : 127 - 138
  • [9] Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study
    De Angelis, Roberta
    Sant, Milena
    Coleman, Michel P.
    Francisci, Silvia
    Baili, Paolo
    Pierannunzio, Daniela
    Trama, Annalisa
    Visser, Otto
    Brenner, Hermann
    Ardanaz, Eva
    Bielska-Lasota, Magdalena
    Engholm, Gerda
    Nennecke, Alice
    Siesling, Sabine
    Berrino, Franco
    Capocaccia, Riccardo
    [J]. LANCET ONCOLOGY, 2014, 15 (01) : 23 - 34
  • [10] Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients
    Hansen, Rikke P.
    Vedsted, Peter
    Sokolowski, Ineta
    Sondergaard, Jens
    Olesen, Frede
    [J]. BMC HEALTH SERVICES RESEARCH, 2011, 11